-
Romidepsin, sold
under the
brand name Istodax, is an
anticancer agent used in
cutaneous T-cell
lymphoma (CTCL) and
other peripheral T-cell
lymphomas (PTCLs)...
-
Docetaxel Larotaxel Pa****axel
Taxotere Tesetaxel Ixabepilone Entinostat Romidepsin Vorinostat Zabadinostat Belotecan Camptothecin Exatecan Gimatecan Irinotecan...
-
cyclic tetrapeptides (such as
trapoxin B, and the depsipeptides, such as
romidepsin benzamides,
electrophilic ketones, and the
aliphatic acid
compounds such...
- 5-azacytidine,
romidepsin and
other DMNT
inhibitors (i.e. 5-azacytidine, hydralazine, 5-Aza-2’-deoxycytidine) and HDAC
inhibitors (i.e.
romidepsin, belinostat...
-
Vorinostat (Zolinza) a
hydroxymate histone deacetylase (HDAC)
inhibitor (2009)
Romidepsin (Istodax) a
cyclic peptide histone deacetylase (HDAC)
inhibitor (2018)...
-
Panobinostat Parthenolide Phenylbutyrate Pracinostat Quisinostat Resminostat Romidepsin Scriptaid Sodium butyrate Sodium oxybate (GHB sodium)
Sodium phenylbutyrate...
-
Panobinostat Parthenolide Phenylbutyrate Pracinostat Quisinostat Resminostat Romidepsin Scriptaid Sodium butyrate Sodium oxybate (GHB sodium)
Sodium phenylbutyrate...
-
acetate Olaparib Rucaparib) HDAC (Belinostat
Entinostat Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib
Copanlisib Duvelisib Idelalisib Umbralisib‡)...
-
acetate Olaparib Rucaparib) HDAC (Belinostat
Entinostat Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib
Copanlisib Duvelisib Idelalisib Umbralisib‡)...
- in
October 2006 for the
treatment of
cutaneous T cell
lymphoma (CTCL).
Romidepsin (trade name Istodax) was
licensed by the US FDA in Nov 2009 for cutaneous...
